Inhibiting Glioblastoma Stem Cells by Targeting Pyruvate Carboxylase: A Novel Therapeutic Strategy with Both Opportunities and Challenges
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Schneider N, Gilreath K, Henriksen N, Donaldson W, Chaudhury S, St Maurice M
. Synthesis and Evaluation of 1,3-Disubstituted Imidazolidine-2,4,5-triones as Inhibitors of Pyruvate Carboxylase. ACS Med Chem Lett. 2024; 15(7):1088-1093.
PMC: 11247459.
DOI: 10.1021/acsmedchemlett.4c00183.
View
2.
Oizel K, Chauvin C, Oliver L, Gratas C, Geraldo F, Jarry U
. Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity. Clin Cancer Res. 2017; 23(20):6292-6304.
DOI: 10.1158/1078-0432.CCR-16-3102.
View
3.
Prager B, Bhargava S, Mahadev V, Hubert C, Rich J
. Glioblastoma Stem Cells: Driving Resilience through Chaos. Trends Cancer. 2020; 6(3):223-235.
PMC: 8779821.
DOI: 10.1016/j.trecan.2020.01.009.
View
4.
Schousboe A, Waagepetersen H, Sonnewald U
. Astrocytic pyruvate carboxylation: Status after 35 years. J Neurosci Res. 2019; 97(8):890-896.
DOI: 10.1002/jnr.24402.
View
5.
McKenna M
. The glutamate-glutamine cycle is not stoichiometric: fates of glutamate in brain. J Neurosci Res. 2007; 85(15):3347-58.
DOI: 10.1002/jnr.21444.
View